Body

Enzyme modification could advance treatment of genetic dieases

Scientists from the Université de Montréal and McGill University have re-engineered a human enzyme, a protein that accelerates chemical reactions within the human body, to become highly resistant to harmful agents such as chemotherapy, according to a new study published in The Journal of Biological Chemistry.

Study of hypertension in sickle cell patients cut short

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial testing a drug treatment for pulmonary hypertension in adults with sickle cell disease nearly one year early due to safety concerns.

Tiny early stage ovarian tumors define early detection challenge

A new study by Howard Hughes Medical Institute researchers shows that most early-stage ovarian tumors exist for years at a size that is a thousand times smaller than existing tests can detect reliably.

But the researchers say their findings also point to new opportunities for detecting ovarian cancer—a roughly four-year window during which most tumors are big enough to be seen with a microscope, but have not yet spread.

Extinction crisis looms in Oceania: Landmark study

Governments must act urgently to halt loss of habitats and invading species that are posing major threats to biodiversity and causing species extinctions across Australia, New Zealand and the Pacific Islands, according to a landmark new study.

University of Toronto helps to 'barcode' the world's plants

An international team of scientists, including botanists from the University of Toronto, have identified a pair of genes which can be used to catalogue the world's plants using a technique known as DNA barcoding — a rapid and automated classification method that uses a short genetic marker in an organism's DNA to identify it as belonging to a particular species.

Nitrous gases and zinc in the crosshairs

The Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area established by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has issued the MAK and BAT Values List for 2009. This year's list contains 62 changes and new entries.

Fox Chase researchers uncover one force behind the MYC oncogene in many cancers

Philadelphia (July 27, 2009) – DLX5, a gene crucial for embryonic development, promotes cancer by activating the expression of the known oncogene, MYC, according to researchers from Fox Chase Cancer Center. Since the DLX5 gene is inactive in normal adults, it may be an ideal target for future anti-cancer drugs, they reason. Their findings are published in the July 31 edition of the Journal of Biological Chemistry, available online now.

Microbes and their hosts -- exploring the complexity of symbiosis in DNA and cell biology

New Rochelle, NY, July 28, 2009—The unique association between microorganisms and their hosts, whether insects, plants, or mammals, provides a fascinating view into how microbial symbionts adapt to changing biological environments. Insights into the diversity and complexity of symbiotic relationships are the focus of the current special issue of DNA and Cell Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. The issue is available free online at www.liebertpub.com/dna

Maternal, paternal genes' tug-of-war may last well into childhood

CAMBRIDGE, Mass., July 28, 2009 -- An analysis of rare genetic disorders in which children lack some genes from one parent suggests that maternal and paternal genes engage in a subtle tug-of-war well into childhood, and possibly as late as the onset of puberty.

Extinct rodent species discovered

An international team of scientists has discovered an extinct rodent species, based on fossil tooth remains found in Alborache, Valencia. Eomyops noeliae, from the Eomyidae family, represents the oldest find within this genus in the world.

UCSF team focuses on patient safety in ambulatory care system

Health care experts at the University of California, San Francisco highlight in a new report the hidden risks and complexities that compromise patient safety for ambulatory patients with chronic disease.

While most prior research in patient safety has focused on preventing medical errors during hospital stays, the UCSF team emphasizes that more attention should be paid to chronic disease patients who receive care on an outpatient basis.

Biologists rediscover endangered frog population

For the first time in nearly 50 years, a population of a nearly extinct frog has been rediscovered in the San Bernardino National Forest's San Jacinto Wilderness. Biologists from the U.S. Geological Survey (USGS) assessing suitability of sites to re-establish frogs and scientists from the San Diego Natural History Museum retracing a 1908 natural history expedition both rediscovered the rare mountain yellow-legged frog in the San Jacinto Wilderness near Idyllwild, Calif.

Coronary calcium scoring could help doctors prevent heart attacks

OAK BROOK, Ill. – Researchers may be able to predict future severe cardiac events in patients with known, stable coronary artery disease (CAD) using coronary calcium scoring, according to a study published in the online edition of Radiology.

Stress signals link pre-existing sickness with susceptibility to bacterial infection

Mitochondrial diseases disrupt the power generating machinery within cells and increase a person's susceptibility to bacterial infection, particularly in the lungs or respiratory tract. A new study published in Disease Models & Mechanisms (DMM), shows that infection with the pneumonia causing bacteria Legionella, is facilitated by an increased amount of a signaling protein that is associated with mitochondrial disease.

Artificial intelligence helps doctors diagnose metastatic cancer

WASHINGTON, D.C. July 28, 2009 -- When doctors are managing care for women with breast cancer, the information available to them profoundly influences the type of care they recommend. Knowing whether a woman's cancer has metastasized, for instance, directly affects how her doctors will approach treatment -- which may in turn influence the outcome of that treatment.